Relation of sensory peripheral neuropathy in sjögren syndrome to Anti-Ro/SSA

Journal of Clinical Rheumatology

Volumn 18, Issue 6, 2012, Pages 290-293

  Scofield, Amanda Kyle ^a   Radfar, Lida ^b   Ice, John A ^a   Vista, Evan ^g   Anaya, Juan Manuel ^h   Houston, Glen ^b   Lewis, David ^b   Stone, Donald U ^b,c   Chodosh, James ^d   Hefner, Kimberly ^a   Lessard, Christopher J ^a   Moser, Kathy L ^a,e   Scofield, Robert Hal ^a,e,f  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b University of Oklahoma   (United States)

^c McGee Eye Institute   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Department of Pathology ^*  (United States)

^f Affairs Medical Center   (United States)

^g Petroleum Engineering Department   (Colombia)

^h UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Autoantibodies; Peripheral neuropathy; Sj gren syndrome; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; LA ANTIBODY; RO ANTIBODY;

ADULT; ARTICLE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; ENZYME LINKED MICROTITER PLATE ASSAY; FEMALE; HUMAN; IMMUNODIFFUSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROPRIOCEPTION; SENSORY NEUROPATHY; SJOEGREN SYNDROME; VIBRATION; VITAMIN BLOOD LEVEL;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; COHORT STUDIES; FEMALE; HUMANS; IMMUNODIFFUSION; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME; VITAMIN B 12;

EID: 84868231431     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3182675e4f     Document Type: Article

References (27)

1. Fox RI. Sjogren syndrome. Lancet. 2005;366:321-331.
2. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren syndrome: A revisal of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558. (Pubitemid 34539104)
3. Helmick CG, Felson DT, Lawrence RC, et al National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15-25.
4. Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjogren syndromeYassociated neuropathy. Brain. 2005;128:2518-2534. (Pubitemid 41552938)
5. Daniels TE. Labial salivary gland biopsy in Sjogren syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984;27:147-156. (Pubitemid 14191019)
6. Routsias JG, Tzioufas AG. Sjogren syndromeVstudy of autoantigens and autoantibodies. Clin Rev All Immunol. 2007;32:238-251.
7. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Aller Immunol. 2007;32:265-274. (Pubitemid 350242572)
8. Addison T. AnaemiaVdisease of the suprarenal capsules. Med Gazette. 1849;43:517-518.
9. Graner JL. Addison, pernicious anemia and adrenal insufficiency. Can Med Assoc J. 1985;133:858-858.
10. Dali-Youcef N, Andres E. An update on cobalamin deficiency in adults. QJM. 2009;102:17-28.
11. Healton EB, Savage DG, Brust JC, et al. Neurologic aspects of cobalamin deficiency. Medicine. 1991;70:229-245.
12. Oyer DS, Saxon D, Shah A. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test. End Pract. 2007;13:5-10.
13. McGill M, Molyneauz L, Yue DK. Use of the Semmes-Weinstein 5.07/10 gram monofilament: The long and the short of it. Diabet Med. 1998;15:615-617. (Pubitemid 28319945)
14. Clark G, Reichlin M, Tomasi TB Jr. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol. 1969;102:117-122.
15. Gordon P, Khamashta MA, Rosenthal E, et al. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol. 2004;31:2480-2487. (Pubitemid 39603101)
16. Aggarwal R, Namjou B, Li S, et al. Male only systemic lupus. J Rheumatol. 2010;37:1480-1487.
17. Provost TT, Vasily D, Alexander E. Sjogren syndrome. Cutaneous, immunologic, and nervous system manifestations. Neurol Clin. 1987;5:405-426. (Pubitemid 17148949)
18. Talal N, Zisman E, Schur PH. Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjogren syndrome. Arthritis Rheum. 1968;11:774-786.
19. Fischer A, Swigris JJ, du Bois RM, et al. Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest. 2009;136:1072-1078.
20. Vernino S, Wolfe GI. Antibody testing in peripheral neuropathies. Neurol Clin. 2007;25:29-46. (Pubitemid 46283308)
21. Alexander EL, Arnett FC, Provost TT, et al. Sjogren's syndrome: Association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983;98:155-159. (Pubitemid 13190911)
22. Sene D, Jallouli M, Lefaucheur JP, et al. Peripheral neuropathies associated with primary Sjogren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine. 2011;90:133-138.
23. Gono T, Kawaguchi Y, Katsumata Y, et al. Clinical manifestations of neurological involvement in primary Sjogren's syndrome. Clin Rheumatol. 2011;30:485-490.
24. Pavlakis PP, Alexopoulos H, Kosmidis ML, et al. Peripheral neuropathies in Sjogren syndrome: A new reappraisal. J Neurol Neurosurg Psychiatry. 2011;82:798-802.
25. Chai J, Herrmann DN, Stanton M, et al. Painful small-fiber neuropathy in Sjogren syndrome. Neurol. 2005;65:925-927. (Pubitemid 41362143)
26. Lorber M, Gershwin ME, Shoenfeld Y. The coexistence of systemic lupus erythematosus with other autoimmune diseases: The kaleidoscope of autoimmunity. Semin Arthritis Rheum. 1994;24:105-113. (Pubitemid 24326548)
27. Ramos-Casals M, Solans R, Rosas J, et al. GEMESS Study Group. Primary Sjogren syndrome in Spain: Clinical and immunologic expression in 1010 patients. Medicine. 2008;87:210-219.